These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15075628)

  • 1. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2/3 antagonists.
    Cook CD; Beardsley PM
    Behav Pharmacol; 2004 Feb; 15(1):65-74. PubMed ID: 15075628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists.
    Cook CD; Beardsley PM
    Behav Pharmacol; 2004 Feb; 15(1):75-83. PubMed ID: 15075629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.
    Cook CD; Beardsley PM
    Pharmacol Biochem Behav; 2003 May; 75(2):363-71. PubMed ID: 12873628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.
    Azaryan AV; Clock BJ; Cox BM
    Neurochem Res; 1996 Nov; 21(11):1411-5. PubMed ID: 8947931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.
    Cook CD; Newman JL; Winfree JC; Beardsley PM
    Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD; Rodefer JS; Picker MJ
    Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Cook CD; Picker MJ
    Psychopharmacology (Berl); 1998 Mar; 136(1):59-69. PubMed ID: 9537683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
    Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentazocine-like discriminative stimulus effects of morphine are blocked by the dopamine D-1 antagonist SCH23390, but not by the dopamine D-2 antagonist sulpiride.
    Ukai M; Hiraiwa E; Kameyama T
    Brain Res; 1991 Feb; 541(1):146-8. PubMed ID: 1827610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mu-, delta- and kappa-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats.
    Woolfolk DR; Holtzman SG
    Drug Alcohol Depend; 1997 Dec; 48(3):209-20. PubMed ID: 9449020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective D1 and D2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin.
    Corrigall WA; Coen KM
    Pharmacol Biochem Behav; 1990 Feb; 35(2):351-5. PubMed ID: 2181485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat.
    Cook CD; Barrett AC; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2000 Sep; 152(1):14-23. PubMed ID: 11041311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.
    Powell KR; Koppelman LF; Holtzman SG
    Behav Pharmacol; 1999 Dec; 10(8):707-16. PubMed ID: 10780285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.